Xiaoxue Xu - Search Results

Year	Number of Results
2006	1
2010	2
2012	3
2013	4
2014	5
2015	9
2016	10
2017	8
2018	14
2019	4
2020	12
2021	11
2022	22
2023	17
2024	13

1

Topical hemostatic materials for coagulopathy.

Hu B, Bao G, Xu X, Yang K. Hu B, et al. Among authors: xu x. J Mater Chem B. 2022 Mar 23;10(12):1946-1959. doi: 10.1039/d1tb02523f. J Mater Chem B. 2022. PMID: 35230377 Review.

2

Research progress on tumor hypoxia-associative nanomedicine.

Xu XX, Chen SY, Yi NB, Li X, Chen SL, Lei Z, Cheng DB, Sun T. Xu XX, et al. J Control Release. 2022 Oct;350:829-840. doi: 10.1016/j.jconrel.2022.09.003. Epub 2022 Sep 13. J Control Release. 2022. PMID: 36100192 Review.

3

Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.

Xu X, Sun B, Zhao C. Xu X, et al. Neurobiol Dis. 2023 Oct 15;187:106314. doi: 10.1016/j.nbd.2023.106314. Epub 2023 Oct 1. Neurobiol Dis. 2023. PMID: 37783233 Free article. Review.

4

The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity.

Wang M, Huang Y, Xin M, Li T, Wang X, Fang Y, Liang S, Cai T, Xu X, Dong L, Wang C, Xu Z, Song X, Li J, Zheng Y, Sun W, Li L. Wang M, et al. Among authors: xu x. Front Immunol. 2023 May 16;14:1156471. doi: 10.3389/fimmu.2023.1156471. eCollection 2023. Front Immunol. 2023. PMID: 37266441 Free PMC article. Review.

5

Near Infrared Light Triggered Photo/Immuno-Therapy Toward Cancers.

Xu X, Lu H, Lee R. Xu X, et al. Front Bioeng Biotechnol. 2020 May 26;8:488. doi: 10.3389/fbioe.2020.00488. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32528941 Free PMC article. Review.

6

Nanomaterials Solutions for Contraception: Concerns, Advances, and Prospects.

Su Z, Diao T, McGuire H, Yao C, Yang L, Bao G, Xu X, He B, Zheng Y. Su Z, et al. Among authors: xu x. ACS Nano. 2023 Nov 14;17(21):20753-20775. doi: 10.1021/acsnano.3c04366. Epub 2023 Oct 19. ACS Nano. 2023. PMID: 37856253 Review.

7

Recent advances in the intracellular delivery of macromolecule therapeutics.

Chen SY, Xu XX, Li X, Yi NB, Li SZ, Xiang XC, Cheng DB, Sun T. Chen SY, et al. Biomater Sci. 2022 Nov 22;10(23):6642-6655. doi: 10.1039/d2bm01348g. Biomater Sci. 2022. PMID: 36214257 Review.

8

Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus.

Siwakoti P, Rennie C, Huang Y, Li JJ, Tuch BE, McClements L, Xu X. Siwakoti P, et al. Among authors: xu x. Stem Cell Rev Rep. 2023 Apr;19(3):601-624. doi: 10.1007/s12015-022-10482-1. Epub 2022 Nov 25. Stem Cell Rev Rep. 2023. PMID: 36434300 Review.

9

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds.

Yang B, Xin M, Liang S, Xu X, Cai T, Dong L, Wang C, Wang M, Cui Y, Song X, Sun J, Sun W. Yang B, et al. Among authors: xu x. Front Pharmacol. 2022 Nov 22;13:1026246. doi: 10.3389/fphar.2022.1026246. eCollection 2022. Front Pharmacol. 2022. PMID: 36483739 Free PMC article. Review.

10

Optical Nonlinearity Enabled Super-Resolved Multiplexing Microscopy.

Ding L, Chen C, Shan X, Liu B, Wang D, Du Z, Zhao G, Su QP, Yang Y, Halkon B, Tran TT, Liao J, Aharonovich I, Zhang M, Cheng F, Fu L, Xu X, Wang F. Ding L, et al. Among authors: xu x. Adv Mater. 2024 Jan;36(2):e2308844. doi: 10.1002/adma.202308844. Epub 2023 Nov 27. Adv Mater. 2024. PMID: 37972577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year